Cargando…
Osteoprotegerin (OPG) Promotes Recruitment of Endothelial Progenitor Cells (EPCs) via CXCR4 Signaling Pathway to Improve Bone Defect Repair
BACKGROUND: The aim of this study was to investigate the effect of using osteoprotegerin (OPG) to treat bone defects mediated by endothelial progenitor cell (EPC) recruitment and migration through the CXCR4 signaling pathway. MATERIAL/METHODS: The EPCs extracted from human peripheral blood were cult...
Autores principales: | Zhang, Rongfeng, Liu, Jianwei, Yu, Shengpeng, Sun, Dong, Wang, Xiaohua, Fu, Jingshu, Shen, Jie, Xie, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681686/ https://www.ncbi.nlm.nih.gov/pubmed/31350844 http://dx.doi.org/10.12659/MSM.916838 |
Ejemplares similares
-
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010) -
Atorvastatin Protects Against Cerebral Aneurysmal Degenerative Pathology by Promoting Endothelial Progenitor Cells (EPC) Mobilization and Attenuating Vascular Deterioration in a Rat Model
por: Wei, Huijie, et al.
Publicado: (2019) -
Effects of physical activity on endothelial progenitor cells (EPCs)
por: De Biase, Chiara, et al.
Publicado: (2014) -
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
por: Bjerre, Mette
Publicado: (2013) -
Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease
por: Bolon, B, et al.
Publicado: (2001)